Omeros Corporation   Report issue

For profit Phase 2 Phase 3 Phase 4
Founded: Seattle WA United States (1994)

Organization Overview

First Clinical Trial
2007
NCT00599664
First Marketed Drug
2014
ketorolac (acuvail)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

OMEROS | Omeros Corporation